ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Tools
Markets
Discover
Subscribe Login/Register Profile Icon
S&P ASX 200
7,194.90
(
0.3%
)
S&P ASX All Technology
2,523.80
(
-0.39%
)
Brent Oil
75.965
(
0.0%
)
US Dollar vs AUD
1.51906
(
0.0%
)
Bitcoin
43,801.82
(
0.19%
)
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Xencor Inc (XNCR)

  7. Xencor Inc (XNCR) News

XNCR Xencor Inc

20.25
0.04 (0.2%)
09 Dec 2023 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Xencor Inc XNCR NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.04 0.2% 20.25 12:00:00
Open Price Low Price High Price Close Price Previous Close
20.16 19.77 20.58 20.25 20.21
more quote information »

Recent News

Date Time Source Heading
22/11/202308:01BWXencor to Present at the Piper Sandler 35th Annual..
16/11/202308:02EDGAR2Form 8-K - Current report
08/11/202308:04EDGAR2Form 8-K - Current report
08/11/202308:03EDGAR2Form 8-K - Current report
08/11/202308:01BWXencor Sells Portion of Royalties and Milestones from..
04/11/202303:01BWXencor Presents Preclinical Data from Multiple XmAb®..
01/11/202307:01BWXencor to Host Third Quarter 2023 Financial Results Webcast..
26/10/202323:11EDGAR2Form 8-K - Current report
26/10/202323:01BWXencor Announces Planned Retirement of Chief Financial..
27/9/202323:01BWXencor to Present Multiple Posters at the SITC Annual..
20/9/202306:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/9/202306:31EDGAR2Form 8-K - Current report
20/9/202306:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
20/9/202306:01BWXencor Appoints Barbara J. Klencke, M.D., to Board of..
04/8/202307:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/8/202306:02EDGAR2Form 8-K - Current report
04/8/202306:01BWXencor Reports Second Quarter 2023 Financial Results
27/7/202322:01BWXencor to Host Second Quarter 2023 Financial Results Webcast..
03/7/202321:16EDGAR2Form 8-K - Current report
31/5/202308:01BWXencor Presents Clinical Results from Phase 1a Study of..
09/5/202306:01BWXencor Reports First Quarter 2023 Financial Results
02/5/202306:01BWXencor to Host First Quarter 2023 Financial Results Webcast..
26/4/202322:01BWXencor Appoints Nancy Valente, M.D., as Chief Development..
18/4/202303:31BWXencor Highlights CD28 Bispecific Antibody Platform at AACR..
15/3/202307:31BWXencor to Present Preclinical Data from Novel XmAb® CD28..
24/2/202308:01BWXencor Reports Fourth Quarter and Full Year 2022 Financial..
17/2/202308:01BWXencor to Report Fourth Quarter and Full Year 2022 Financial..
08/2/202308:01BWXencor to Present at the SVB Securities Global Biopharma..
10/1/202300:01BWXencor Highlights 2023 Corporate Priorities and Provides..
05/1/202322:30PRNUSCaris Life Sciences and Xencor Expand Target Discovery..
05/1/202308:01BWXencor to Present at the 41st Annual J.P. Morgan Healthcare..
13/12/202202:00BWXencor Presents Data from Phase 1 Study of Plamotamab in..

Your Recent History

NASDAQ
XNCR
Xencor
Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com